U.S. Food and Drug Administration (FDA) Advisory
December 12, 2016: Pioglitazone-containing Medicines: As a result of an updated review, the FDA has concluded that use of the type 2 diabetes medicine pioglitazone (Actos, Actoplus Met, Actoplus Met XR, Duetact, Oseni) may be linked to an increased risk of bladder cancer. The labels of pioglitazone-containing medicines already contain warnings about this risk, and FDA has approved label updates to describe the additional studies reviewed.
Registration is now open for the Evidence-based Guidelines Affecting Policy, Practice and Stakeholders (E-GAPPS III) Conference. It will be held March 20-21, 2017 at The New York Academy of Medicine. The event is sponsored by the Guidelines International Network North America (G-I-N NA) and NYAM's Section on Evidence Based Health Care (SEBHC). The conference is titled "Beyond Implementation: Are Clinical Guidelines Improving Healthcare Quality?"
AHRQ Announces Funding Opportunity for Developing Measures of Shared Decisionmaking
A new funding opportunity announcement from AHRQ solicits applications for research projects to develop, test and evaluate measures of shared decisionmaking for research conducted in clinical settings. Shared decisionmaking is a collaborative process in which patients and members of their clinical team make health care decisions that are informed by scientific evidence as well as patients' values and preferences. Each project is expected to produce valid and reliable measures of shared decisionmaking, along with instructions for implementing the measures and documentation on the development, testing and evaluation of the measures. The maximum cost for each project is $500,000 per year and $1.5 million for up to three years.
How to Participate
Submit Guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
Suggest a Guideline for Possible Inclusion: Submit your suggestions for evidence-based clinical practice guidelines that you would like to see included in NGC